metadoxine

DRUG4 trials

Sponsors

Brown University, PharmaKing, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Hospital General de Mexico

Conditions

Alcoholic Fatty Liver DiseaseAlcoholic HepatitisAlcoholic Liver DiseaseAlcoholism,NAFLDNon-alcoholic SteatohepatitisPre-diabetes

Phase 2

A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease

CompletedNCT01504295

Brown UniversityAlcoholic Liver Disease, Alcoholism,

Start: 2012-04-30End: 2015-02-28Updated: 2015-07-22

Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis

CompletedNCT02019056

PharmaKingAlcoholic Fatty Liver Disease, Alcoholic Hepatitis

Start: 2010-11-30End: 2014-12-31Updated: 2015-04-29

Phase 3

Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis

WithdrawnNCT02541045

Hospital General de MexicoNon-alcoholic Steatohepatitis

Start: 2015-08-31End: 2024-03-31Updated: 2024-03-15

Phase 4

Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis

Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranNAFLD, Pre-diabetes

Start: 2016-01-31End: 2020-12-31Target: 100Updated: 2019-01-31